PARP1 and cancer: Similarly, after prolonged exposure to a PARP inhibitor-exposed environment, several cancer cell lines, such as the JHOS4-PR, PEO1-PR, and UWB1.289 SYR cell lines, evolved acquired resistance compared to their parental counterparts.